These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17826047)

  • 21. Bioequivalence for topical products--an update.
    Narkar Y
    Pharm Res; 2010 Dec; 27(12):2590-601. PubMed ID: 20859663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical factors determining the potency of topical corticosteroids.
    Kirkland R; Pearce DJ; Balkrishnan R; Feldman SR
    J Dermatolog Treat; 2006; 17(3):133-5. PubMed ID: 16854751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of cutaneous drug delivery using microdialysis.
    Kreilgaard M
    Adv Drug Deliv Rev; 2002 Nov; 54 Suppl 1():S99-121. PubMed ID: 12460718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug biodisponibility and generic equivalence (author's transl)].
    Jaminet F
    J Pharm Belg; 1977; 32(4):325-46. PubMed ID: 599404
    [No Abstract]   [Full Text] [Related]  

  • 25. Ranking of topical glucocorticoids. Principles and results.
    Smith EW; Haigh JM
    Curr Probl Dermatol; 1993; 21():89-96. PubMed ID: 8299381
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bioavailability and the assessment of bioequivalence in the control of pharmaceutical preparations].
    Ciranni Signoretti E
    Ann Ist Super Sanita; 1982; 18(3):547-50. PubMed ID: 7187843
    [No Abstract]   [Full Text] [Related]  

  • 27. [The connections between structure, pharmacokinetics and effects of glucocorticoids].
    Lutz F
    Tierarztl Prax; 1988; 16(4):333-41. PubMed ID: 3065978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interpatient variability in bioavailability is related to the extent of absorption: implications for bioavailability and bioequivalence studies.
    Hellriegel ET; Bjornsson TD; Hauck WW
    Clin Pharmacol Ther; 1996 Dec; 60(6):601-7. PubMed ID: 8988062
    [No Abstract]   [Full Text] [Related]  

  • 29. Requirements for submission of bioequivalence data; final rule. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Jan; 74(11):2849-62. PubMed ID: 19385107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced systems for glucocorticoids' dermal delivery.
    Raposo SC; Simões SD; Almeida AJ; Ribeiro HM
    Expert Opin Drug Deliv; 2013 Jun; 10(6):857-77. PubMed ID: 23544712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous Pharmacokinetic Approaches to Compare Bioavailability and/or Bioequivalence for Topical Drug Products.
    Raney SG; Ghosh P; Ramezanli T; Lehman PA; Franz TJ
    Dermatol Clin; 2022 Jul; 40(3):319-332. PubMed ID: 35750415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [What happens in the body with glucocorticoids? Pharmacokinetics and pharmacodynamics].
    Högger P
    Pharm Unserer Zeit; 2003; 32(4):296-301. PubMed ID: 12899066
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bioequivalence study of sinomenine patch by microdialysis].
    Ling JJ; Wang Y; Xie B; Zhou LL
    Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(21):2482-5. PubMed ID: 19149253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal response to glucocorticoid treatment.
    Vanpee D; Gillet JB
    Lancet; 2000 Apr; 355(9213):1458; author reply 1459. PubMed ID: 10791542
    [No Abstract]   [Full Text] [Related]  

  • 35. [Between Cortisone anxiety and euphoria. Pharmaceutical surveillance of long-term medication].
    Bertsche T; Schulz M
    Pharm Unserer Zeit; 2003; 32(4):323-9. PubMed ID: 12899070
    [No Abstract]   [Full Text] [Related]  

  • 36. [Adhesive cutaneous pharmaceutical forms].
    Gafiţanu E; Matei I; Mungiu OC; Pavelescu M; Mîndreci I; Apostol I; Ionescu G
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(4):771-6. PubMed ID: 2636779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Are therapeutic drugs freely interchangeable? Studies of bioavailability and bioequivalence].
    Blume H
    Verh Dtsch Ges Inn Med; 1988; 94():411-9. PubMed ID: 3061214
    [No Abstract]   [Full Text] [Related]  

  • 38. Dermatokinetics as an Important Tool to Assess the Bioavailability of Drugs by Topical Nanocarriers.
    Thotakura N; Kumar P; Wadhwa S; Raza K; Katare P
    Curr Drug Metab; 2017; 18(5):404-411. PubMed ID: 28266274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vasoconstrictor assay in bioequivalence testing: practical concerns and recent developments.
    Stoughton RB
    Int J Dermatol; 1992 Oct; 31 Suppl 1():26-8. PubMed ID: 1428464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Determination of the effect of formulation on the bioavailability of topical corticoids by non-contact reflectometry].
    Le Gall F; Levèque JL; Poelman MC
    Pharm Acta Helv; 1985; 60(4):125-8. PubMed ID: 4011625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.